Literature DB >> 11337986

Comparative investigation of human stratum corneum ceramides.

J P Vietzke1, O Brandt, D Abeck, C Rapp, M Strassner, V Schreiner, U Hintze.   

Abstract

The stratum corneum (SC) requires ceramides, cholesterol, and fatty acids to provide the cutaneous permeability barrier. SC lipids can be analyzed by normal-phase high-performance thin-layer chromatography (HPTLC). However, without further analysis, some uncertainty remains about the molecular composition of lipids represented by every TLC band of an unknown sample. We therefore analyzed each ceramide band further by subjecting the isolated lipids to a direct coupling of reversed-phase high-performance liquid chromatography and electrospray ionization-mass spectrometry (HPLC/ESI-MS, or LC/MS). LC/MS analysis and ESI-MS/MS negative ion and collision-induced dissociation experiments revealed that ceramide band 4 contained not only N-(omega-OH-acyl)acyl-6-OH-sphingosine, Cer(EOH), but also N-(alpha-OH-acyl)-sphingosine. Band 5 exclusively contained N-acyl-6-OH-sphingosine. Our results demonstrate the benefit of LC/MS analysis for selective identification of human SC ceramides. Moreover, the combination of HPTLC for pre-separation and LC/MS for identification of lipids is an even more powerful tool for detailed ceramide analysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337986     DOI: 10.1007/s11745-001-0721-9

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  23 in total

1.  Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema.

Authors:  O Bleck; D Abeck; J Ring; U Hoppe; J P Vietzke; R Wolber; O Brandt; V Schreiner
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

Review 2.  The biochemistry and function of stratum corneum lipids.

Authors:  N Y Schurer; P M Elias
Journal:  Adv Lipid Res       Date:  1991

3.  A new 6-hydroxy-4-sphingenine-containing ceramide in human skin.

Authors:  M E Stewart; D T Downing
Journal:  J Lipid Res       Date:  1999-08       Impact factor: 5.922

4.  Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS).

Authors:  G Liebisch; W Drobnik; M Reil; B Trümbach; R Arnecke; B Olgemöller; A Roscher; G Schmitz
Journal:  J Lipid Res       Date:  1999-08       Impact factor: 5.922

Review 5.  [Regulation of the epidermal permeability barrier by lipids and hyperproliferation].

Authors:  E Proksch
Journal:  Hautarzt       Date:  1992-06       Impact factor: 0.751

6.  Skin lipids.

Authors:  G Brooks; B Idson
Journal:  Int J Cosmet Sci       Date:  1991-04       Impact factor: 2.970

7.  Stratum corneum lipid abnormalities in atopic dermatitis.

Authors:  A Yamamoto; S Serizawa; M Ito; Y Sato
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

8.  Structure determination of glucosyl beta 1-N-(omega-O-linoleoyl)-acylsphingosines of human epidermis.

Authors:  S Hamanaka; C Asagami; M Suzuki; F Inagaki; A Suzuki
Journal:  J Biochem       Date:  1989-05       Impact factor: 3.387

9.  Skin lipids: an update.

Authors:  D T Downing; M E Stewart; P W Wertz; S W Colton; W Abraham; J S Strauss
Journal:  J Invest Dermatol       Date:  1987-03       Impact factor: 8.551

10.  6-Hydroxy-4-sphingenine in human epidermal ceramides.

Authors:  K J Robson; M E Stewart; S Michelsen; N D Lazo; D T Downing
Journal:  J Lipid Res       Date:  1994-11       Impact factor: 5.922

View more
  9 in total

1.  Highly sensitive determination of diverse ceramides in human hair using reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry.

Authors:  Yoshinori Masukawa; Hisashi Tsujimura
Journal:  Lipids       Date:  2007-01-19       Impact factor: 1.880

2.  Determination of fatty acid and sphingoid base composition of eleven ceramide subclasses in stratum corneum by UHPLC/scheduled-MRM.

Authors:  Gilbert P Laffet; Alexandre Genette; Bastien Gamboa; Virginie Auroy; Johannes J Voegel
Journal:  Metabolomics       Date:  2018-05-09       Impact factor: 4.290

3.  LC/MS analysis of stratum corneum lipids: ceramide profiling and discovery.

Authors:  Jeroen van Smeden; Louise Hoppel; Rob van der Heijden; Thomas Hankemeier; Rob J Vreeken; Joke A Bouwstra
Journal:  J Lipid Res       Date:  2011-03-28       Impact factor: 5.922

4.  Characterization of ceramides by low energy collisional-activated dissociation tandem mass spectrometry with negative-ion electrospray ionization.

Authors:  Fong-Fu Hsu; John Turk
Journal:  J Am Soc Mass Spectrom       Date:  2002-05       Impact factor: 3.109

5.  Complete structural characterization of ceramides as [M-H]- ions by multiple-stage linear ion trap mass spectrometry.

Authors:  Fong-Fu Hsu
Journal:  Biochimie       Date:  2016-08-12       Impact factor: 4.079

6.  Comprehensive quantification of ceramide species in human stratum corneum.

Authors:  Yoshinori Masukawa; Hirofumi Narita; Hirayuki Sato; Ayano Naoe; Naoki Kondo; Yoshiya Sugai; Tsuyoshi Oba; Rika Homma; Junko Ishikawa; Yutaka Takagi; Takashi Kitahara
Journal:  J Lipid Res       Date:  2009-04-06       Impact factor: 5.922

7.  Nonhydroxylated 1-O-acylceramides in vernix caseosa.

Authors:  Eva Harazim; Vladimír Vrkoslav; Miloš Buděšínský; Petr Harazim; Martin Svoboda; Richard Plavka; Zuzana Bosáková; Josef Cvačka
Journal:  J Lipid Res       Date:  2018-09-25       Impact factor: 5.922

8.  Direct visualization of lipid domains in human skin stratum corneum's lipid membranes: effect of pH and temperature.

Authors:  I Plasencia; L Norlén; L A Bagatolli
Journal:  Biophys J       Date:  2007-07-13       Impact factor: 4.033

9.  Imaging mass spectrometry visualizes ceramides and the pathogenesis of dorfman-chanarin syndrome due to ceramide metabolic abnormality in the skin.

Authors:  Naoko Goto-Inoue; Takahiro Hayasaka; Nobuhiro Zaima; Kimiko Nakajima; Walter M Holleran; Shigetoshi Sano; Yoshikazu Uchida; Mitsutoshi Setou
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.